David Allen May

Director David Allen May purchased 40,250 shares across 3 transactions at $0.53 (totaling $21,151.38), raising holdings 34.6% despite stock down 86.4% from 52-week high.

David Allen May, a Director at SurgePays, executed 3 separate purchases totaling 40,250 shares for $21,151.38 between June 3–5, 2026, at a blended price of $0.53 per share. This acquisition increased his holdings from 116,376 to 156,626 shares (+34.6%). The purchases occurred while the stock trades at $0.47, approximately 86.4% below its 52-week high of $3.45 and down 40.1% over 90 days. May's prior purchases at this ticker (December 2025) both yielded negative 90-day returns (−47.0% and −47.7%), establishing a pattern of poor timing at SURG over the measurable window. The company is unprofitable (net income −$12.1M on revenue $16.0M in the latest quarter) and revenue contracted 6.4% year-over-year, creating fundamental headwinds that complicate interpretation of a discounted-price accumulation.

Director David Allen purchased 38,422 shares at $1.60–$1.62 as stock trades 57.1% below 52-week high amid -55.6% revenue decline.

Director David Allen executed 2 separate purchases totaling 38,422 shares for $61,646.78 at a blended average price of $1.60 on December 10, 2025, raising his holdings 32.1% to 158,116 shares. The purchase occurs as the stock trades at $1.47, down 57.1% from its 52-week high of $3.43 and down 48.4% over the prior 30 days, while the company reports negative net income of -$7,489,068.00 in the latest quarter and annual revenue contraction of -55.6%. This discretionary acquisition by a director of a materially distressed company—operating unprofitably with collapsing revenue growth—at depressed valuations represents a notable accumulation against a backdrop of severe operational deterioration.